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Varicella-zoster virus (VZV) has been known to cause 
intracranial vasculopathy, which can result in various 
cerebrovascular complications such as transient 
ischemic attack, ischemic and hemorrhagic stroke, 
aneurysm, and arterial dissection.1,2 Previous studies 
indicated that the anterior circulation, especially the 
distal internal carotid or proximal middle cerebral ar-
teries, is frequently affected in VZV vasculopathy.3 We 
report a case of VZV vasculopathy involving the verte-
brobasilar system, which was diagnosed and followed 
up with high-resolution vessel wall magnetic resonance 
imaging (HRVW-MRI).
CASE
A 51-year-old man was admitted with sudden left-sid-
ed hemiparesis and dysarthria. He reported no history 
of chronic illnesses, including cancer or autoimmune 
diseases. Six weeks prior to the symptoms, he had vis-
ited the emergency department with severe headache 
and a painful blistering rash behind his right ear and 
posterior neck, leading to a diagnosis of herpes zoster 
and a 7-day prescription of oral valacyclovir.
The initial neurological examination revealed left 
central-type facial palsy and a pronator drift in the left 
arm. His left leg weakness was mild, and he could walk 
without difficulty. The National Institutes of Health 
Stroke Scale score was 3.
Brain magnetic resonance (MR) imaging revealed an 
acute right pontine infarction on the diffusion-weight-
ed image (Fig. 1A). The susceptibility-weighted image 
showed a subarachnoid hemorrhage in the prepontine 
cistern (Fig. 1B, C) and a minimal wall hemorrhage in 
the right distal vertebral artery (VA). MR angiography 
revealed severe stenosis of the right distal VA (Fig. 1D). 
VA dissection was first suspected, and HRVW-MRI was 
performed to confirm the arterial wall pathology.
HRVW-MRI taken 2 days after admission demon-
strated severely tapered right distal VA with concentric 
wall thickening and enhancement, which was strongly 
suggestive of vasculitis (Fig. 1E). The basilar artery (BA) 
was patent without any enhancement (Fig. 1F). Given 
that the vessel wall inflammation may be a pathogenet-
ic factor of arterial dissection,4 vasculitis was concluded 
to be the primary cause of VA dissection.
Varicella-zoster virus (VZV) has been known to cause intracranial vasculopathy. 
Herein, we report the case of a patient with VZV vasculopathy involving the verte-
brobasilar system who underwent serial high-resolution vessel wall magnetic res-
onance imaging (HRVW-MRI). The disease continued to worsen radiographically 
despite clinical symptom improvement. We suggest that VZV vasculopathy may 
exhibit clinicoradiological dissociation that requires ongoing medical attention. 
HRVW-MRI may play a critical role in monitoring the disease activity.
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FIG. 1. Brain magnetic resonance imaging, magnetic resonance angiography (MRA), and vessel wall imaging scans of the present patient. (A-F) 
Initial images. (A) The diffusion-weighted image shows an acute right pontine infarction. (B, C) The susceptibility-weighted images demonstrate 
subarachnoid hemorrhage in the prepontine cistern, originating from trace amounts of hemorrhage in the wall of the right distal vertebral artery 
(VA). (D) The MRA image shows a severe stenosis of the right distal VA. (E, F) The vessel wall images demonstrate concentric wall thickening and 
enhancement of the right distal VA, and a normal basilar artery (BA). (G-I) Two-month follow-up images. (G) The MRA image shows improvement 
of the stenosis of the right distal VA and a newly developed diffuse luminal narrowing of the BA. (H, I) The vessel wall images show a reduction in 
the enhancement of the right distal VA but a newly developed, diffuse, concentric wall thickening and enhancement of the BA. (J-L) Five-month 
follow-up images. (J) The MRA image demonstrates an insignificant change in the stenosis of the vertebrobasilar arteries. (K, L) The vessel wall 
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Laboratory tests were performed to identify various 
causes of cerebral vasculitis. No abnormalities were ob-
served in the complete blood count, routine chemistry 
tests, and urinalysis, indicating a lack of evidence of sys-
temic organ involvement. The results of the antinuclear 
antibody (ANA), perinuclear antineutrophil cytoplasmic 
antibody (p-ANCA), and cytoplasmic antineutrophil 
cytoplasmic antibody (c-ANCA) were all negative. The 
erythrocyte sedimentation rate was 24 mm/hour, which 
showed a slight increase from the normal values of 
0–15 mm/hour, while the C-reactive protein level was 
within its normal range.
Regarding the possibility of VZV vasculopathy oc-
curring up to 6 months after onset of zoster infection1 
and excluding other possible causes, VZV vasculopathy 
was found to be the most likely cause of the vasculitis. 
The patient received oral prednisolone 30 mg/day in 
combination with antiplatelets. Mild dysarthria was the 
only sequelae upon discharge.
Two months later, the patient did not present any 
neurological symptoms. However, follow-up HRVW-
MRI revealed a newly developed, diffuse, concentric 
wall thickening and enhancement of the BA with dif-
fuse luminal narrowing (Fig. 1G-I). We restarted the 
oral valacyclovir and steroid therapies because an active 
vascular inflammation involving the BA was seen. A 
third HRVW-MRI, obtained 5 months after the initial 
stroke, demonstrated a decrease in the extent of the 
enhancement in the right distal VA and BA, and overall 
improvement of vessel wall inflammation and stenosis 
(Fig. 1J-L).
DISCUSSION
The present case demonstrates that VZV vasculopathy 
may also occur in the vertebrobasilar arterial system. 
Direct VZV invasion of cerebral arteries, which leads to 
inflammation and pathological vascular remodeling, 
is thought to be the mechanism of VZV vasculopathy.5 
Thickened intima, disrupted internal elastic lamina, 
and loss of smooth muscle cells were revealed in the 
histological and immunohistochemical studies of 
VZV-infected arteries.5
Diagnosis of VZV vasculopathy is not straightforward, 
as stroke may occur months to years after zoster infec-
tion6 and other risk factors of stroke may coexist. In the 
study of 19 patients with zoster rash, the mean inter-
val from rash to neurological symptoms or signs was 
4.1 months, and the interval ranged from the same day 
to 2.5 years.6 Careful history taking, including recent 
herpes zoster infection, can aid early diagnosis. Obtain-
ing cerebrospinal fluid for the detection of anti-VZV 
antibodies or VZV DNA is recommended to confirm the 
diagnosis.1 However, negative virological findings do 
not always exclude the diagnosis. Reasonable suspicion 
is of importance, and HRVW-MRI may play a critical 
role in diagnosing VZV vasculopathy. HRVW-MRI is 
recognized for its usefulness in differentiating various 
intracranial arterial pathologies such as intracranial 
atherosclerosis, vasculitis, dissection, and reversible 
cerebral vasoconstriction syndrome.7 Imaging findings 
of VZV vasculopathy usually show focal or diffuse areas 
of stenosis in MR angiography or cerebral angiography, 
with corresponding concentric thickening and contrast 
uptake in HRVW-MRI.3
The lack of evidence, strategies for follow-up 
assessment, and treatments for VZV vasculopathy 
still remain elusive. Despite the clinical symptom 
improvement, VZV vasculopathy may continue to 
worsen radiographically as presented in this study. 
The patient showed clinical and radiographic improve-
ments with oral prednisolone therapy, although the 
steroid therapy was once discontinued but was then 
resumed after confirmation of findings suggestive of 
ongoing disease on follow-up HRVW-MRI. The effi-
cacy of prolonged use of steroids for VZV vasculopathy 
is still in question, but treatment with intravenous 
acyclovir therapy is recognized for stabilizing and 
improving vasculopathy.1,5 Given that VZV vasculopathy 
is potentially treatable5 and may exhibit clinicoradio-
logical dissociation that requires ongoing medical 
attention, we recommend that follow-up HRVW-MRI 
should be considered regardless of clinical symptoms 
to monitor the disease activity. However, whether the 
treatment duration should be based on clinical symp-
toms or imaging findings still remains controversial, 
necessitating further investigations.
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